PSA Vice President Professor Mark Naunton MPS[/caption]
Synthetic opioids ‘one of the biggest threats’ to drug-related harm
Australia should prepare now for a potential influx of synthetic opioids into the illicit drug market, an expert has told Australian Pharmacist, as overdoses increase internationally.
New COVID-19 booster advice
Just ahead of an apparent end-of-year surge in COVID-19 cases in the two most populous states, Federal Minister for Health Greg Hunt announced on 12 December that the booster program would be fast-tracked.
Flu cases surge to record highs as vaccination rates stall
While community pharmacists have smashed previous early-season influenza vaccination records, national coverage still lags dangerously.
What can be done about ongoing medicine shortages?
Palliative care patients and children bear the brunt of short supply of medicines. These legislative updates could help to make a difference.
Treatment of acute pain with Pharmacist Only (S3) celecoxib
Effectively managing acute pain is a crucial aspect of patient care. This article explores current Pharmacist Only options for pain management following the recent market entry of Pharmacist Only celecoxib.
Ozempic now indicated to prevent CKD progression
Ozempic is the first medicine in Australia approved to slow kidney disease progression in patients with both type 2 diabetes and CKD.
